Private Label Tranexamic Acid Body Scrub Manufacturer Low MOQ

The minimum order quantity for private label tranexamic acid body scrubs depends heavily on whether you are working with a stock formula, a semi-custom base, or a fully bespoke formulation. Stock-formula manufacturers — those who already have a TXA scrub base validated and on the shelf — can often accommodate MOQs as low as 100 to 250 units per SKU, because the formulation development cost has already been amortized across many clients. Semi-custom work, where you choose your exfoliant type, scent, and TXA concentration but start from a proven base, typically carries an MOQ of 250 to 500 units. Fully custom development — a unique formula built from scratch for your brand — usually requires 500 to 1,000 units minimum because the manufacturer needs to recover R&D, stability testing, and tooling costs. Packaging choice moves the MOQ significantly. Wide-mouth glass jars require a minimum fill-line setup charge; some manufacturers will not run fewer than 500 units in glass because the line clean-down time is not economical. HDPE or PET plastic jars and stand-up pouches are more flexible — some co-packers will go as low as 100 units in those formats. Geography also matters. U.S.-based manufacturers tend to have lower MOQs (100–500) but higher per-unit costs. Asian manufacturers — particularly those in South Korea, which is an active-ingredient scrub powerhouse — often have MOQs of 1,000–3,000 units but significantly lower per-unit costs, sometimes half the price at scale. Factor in 4–6 weeks of additional lead time for overseas production plus freight. A common mistake indie founders make is negotiating the MOQ down so aggressively that the manufacturer shifts to a lower-quality exfoliant or reduces QC steps to protect margin. If a supplier agrees to 50 units with no setup fee and no stability testing requirement, treat that as a red flag rather than a win. For founders still in concept phase, some cosmetic incubators and accelerators offer shared-production slots that allow runs of 50–100 units inside a licensed facility, which is worth exploring before committing to a full contract manufacturer. AJ Cosmo Labs lists suppliers across the full MOQ spectrum so you can filter by your actual run size without wasting time on suppliers who will not quote below 5,000 units.

The total cost to private label a tranexamic acid body scrub breaks into four buckets: formulation and development, stability and compliance testing, packaging, and unit production cost. Formulation and development ranges from $0 to $5,000. If you license a stock TXA scrub base from a manufacturer, development cost is zero — it is baked into the per-unit price. Semi-custom development typically runs $500–$1,500 as a one-time fee. Fully bespoke formulation with a cosmetic chemist can run $2,000–$5,000+ depending on the complexity of the actives stack and the number of revision rounds. Stability and compliance testing is non-negotiable for any product with an active ingredient like tranexamic acid. Accelerated stability testing (12-week protocol at 40°C/75% RH) runs $300–$800 per formula at a third-party lab. Preservative efficacy testing (PET/challenge test) adds another $200–$500. If you are selling in the EU, a Cosmetic Product Safety Report (CPSR) from a qualified safety assessor will cost $600–$1,500. Budgeting $1,000–$2,500 for testing on a first formula is realistic and responsible. Packaging cost depends on format and material. A simple HDPE wide-mouth jar in a 250 mL size, undecorated, costs $0.30–$0.80 per unit at 500-unit volumes. Add a shrink sleeve or a screen-printed label and you are at $0.80–$1.80 per unit. Glass jars run $1.20–$3.00 per unit at similar quantities. Custom-molded packaging requires a mold investment of $3,000–$15,000 and is only viable at 5,000+ units. Per-unit production cost for the scrub itself — filling, capping, labeling, QC — runs $4–$14 at 100–500 units, $3–$6 at 500–2,000 units, and $2–$4 at volumes above 2,000. These ranges reflect U.S. and EU manufacturers; Korean and Chinese manufacturers can be 30–50% lower at equivalent MOQs but carry higher freight and longer lead times. Putting it together: a founder doing a 250-unit first run with a semi-custom formula, stock HDPE jar, and basic label should budget $6,000–$12,000 all-in. That sounds steep, but on a per-unit basis it is $24–$48 — which supports a retail price of $28–$60 depending on positioning. By the second or third run, development costs are eliminated and total spend drops sharply. AJ Cosmo Labs helps founders compare transparent quotes side by side so you are never surprised by hidden setup fees.

The end-to-end timeline for a private label tranexamic acid body scrub runs 8 to 20 weeks depending on formula path, testing requirements, packaging sourcing, and manufacturer location. Here is how the stages stack up. Weeks 1–2 are the brief and supplier alignment phase. You finalize your formula brief — TXA concentration, exfoliant type (sugar, salt, walnut shell, jojoba beads, or pumice), scent direction, viscosity, color, and packaging spec — and execute an NDA and development agreement with your chosen manufacturer. Weeks 2–6 are the sampling phase. Most manufacturers produce an initial sample within 2–3 weeks of brief approval. Expect two to three rounds of revision. Each round takes 1–2 weeks. Common revision triggers include exfoliant particle size feeling too harsh or too fine, fragrance not holding in the base, or TXA concentration causing slight discoloration. Lock your formula at the end of this phase — changes after stability testing starts cost time and money. Weeks 6–14 are the stability and testing phase. Accelerated stability runs for 12 weeks concurrently with the sampling phase wherever possible, but you cannot start it until the formula is locked. Preservative efficacy testing runs 4–6 weeks. If you need a CPSR for EU, that adds 2–4 weeks. Many founders run these in parallel to save calendar time. Weeks 8–12 are the artwork and regulatory phase. Your INCI list must be final before artwork is submitted to print. Label compliance review (net weight, country of origin, distributor address, required warnings) adds 1–2 weeks. Print lead times for labels or shrink sleeves run 2–4 weeks for short runs. Weeks 12–16 are production and QC. Bulk manufacture, filling, capping, labeling, and in-house QC inspection. At MOQs under 1,000 units, production itself typically takes 3–5 business days; the lead time buffer accounts for scheduling at the fill line. Weeks 14–20 account for freight if your manufacturer is overseas. Air freight from South Korea or China is 5–10 days; ocean freight is 25–35 days and cuts cost by 60–70% but adds significant calendar risk. The single biggest timeline killer is artwork changes after production has started. Lock your design before production kicks off. The second biggest killer is formula changes requested after stability has started — you restart the clock. AJ Cosmo Labs helps you stay on track with milestone notifications so nothing slips.

Tranexamic acid is considered safe for cosmetic use at concentrations up to 5% in leave-on and rinse-off formats based on published in-vitro, in-vivo, and clinical data. It works by inhibiting plasminogen activator in keratinocytes, which in turn reduces melanin transfer to the skin surface — making it an effective brightening active for hyperpigmentation, uneven skin tone, and post-inflammatory marks from acne or ingrown hairs, conditions that are common on the body as well as the face. In a rinse-off scrub format, effective concentrations typically range from 2% to 5%. Lower concentrations (1–2%) are sometimes used in combination formulas where TXA is stacked with niacinamide, alpha-arbutin, or vitamin C derivatives to achieve a synergistic brightening effect. At 3–5%, TXA alone provides a meaningful dose in a scrub context, though some formulators argue that leave-on products deliver more sustained exposure to the skin. From a safety and compatibility standpoint, TXA is well-tolerated even on sensitive skin at standard concentrations. It does not carry the irritation risk associated with kojic acid or the regulatory burden of hydroquinone, which is banned in cosmetics in the EU and Canada. It is not a known photosensitizer, which is an advantage for a body product used before sun exposure. Formulation pH is critical. TXA is most stable and most efficacious at pH 5.5–6.5, which aligns well with the skin's natural acid mantle. Formulators must verify that the physical exfoliant and any fragrance or botanical extracts in the base do not shift pH out of this range over shelf life. One compatibility consideration is physical exfoliant particle size. Jagged exfoliants like walnut shell can create micro-tears in skin that temporarily increase permeation of any active, including TXA. This is generally not a safety concern at cosmetic concentrations, but some brands opt for smooth spherical exfoliants (jojoba beads, sugar) to control permeation more predictably and to avoid the regulatory scrutiny that has followed walnut shell scrubs in the EU. For regulatory purposes in the U.S., TXA at standard cosmetic concentrations is classified as a cosmetic ingredient, not a drug. Brands must avoid disease claims ("treats melasma") and stick to appearance claims ("visibly brighter, more even-toned skin"). In the EU, TXA is permitted under Regulation (EC) No 1223/2009 and does not appear on Annexes II, III, IV, or V as a restricted or prohibited substance at typical use levels, making compliance straightforward with a proper CPSR in place.

Finding a vetted private label body scrub manufacturer for small batches — under 500 units — requires a different approach than sourcing at scale, because most traditional manufacturer directories and trade shows are populated by suppliers whose economics only work at 2,000 units or more. The first step is defining your non-negotiables before you start outreach. Write down your target MOQ, your required certifications (ISO 22716, FDA-registered facility, COSMOS-certified if you want organic positioning), your preferred manufacturing geography, and your timeline. Having this brief ready means you can qualify or disqualify a supplier in one conversation instead of three weeks of back-and-forth. For U.S.-based small-batch manufacturers, the Personal Care Products Council member directory and the Independent Cosmetic Manufacturers and Distributors (ICMAD) database are starting points, though they skew toward larger operators. State-level cosmetic manufacturing associations in California, New York, and New Jersey list smaller regional formulators who often work at lower MOQs. For Korean ODM/OEM manufacturers — a strong choice for TXA formulas given South Korea's expertise in skin-brightening actives — look for members of the Korea Cosmetic Industry Institute (KCII) or exhibitors at CosmoBeauty Seoul. Many Korean ODMs have U.S.-facing sales representatives who handle English-language communication and can facilitate lower MOQs for international indie brands. The most time-efficient approach is a marketplace that pre-screens suppliers and lets you post a brief once to reach many. AJ Cosmo Labs is an iOS app built specifically for this workflow — you describe your tranexamic acid body scrub project, set your target MOQ and budget, and vetted cosmetic contract manufacturers and chemists respond to you directly. The app's supplier profiles include certifications, specializations, and MOQ ranges, so you can filter for low-MOQ operators before the first message. When vetting any shortlisted manufacturer, request three things: a reference list of current indie brand clients (call them), a sample stability protocol they have used for a comparable active-ingredient product, and a sample production agreement so you can review IP ownership, kill-fee terms, and escrow or payment milestone structure. A manufacturer who cannot provide any of these within a week of being asked is not operationally ready for a professional partnership, regardless of how low their quoted MOQ is. Common mistakes first-timers make: choosing the cheapest quote without verifying GMP status; not asking who owns the formula IP (some manufacturers retain formula ownership unless you pay a buyout fee); and failing to get a fill tolerance spec in writing, which can lead to disputes if units come in consistently under labeled net weight. AJ Cosmo Labs's escrowed milestone payment system protects founders from the most acute financial risks in this process.

The certifications that matter for a private label body scrub manufacturer depend on your target market, your brand's positioning, and the claims you plan to make. Here is a practical breakdown. ISO 22716 (GMP for Cosmetics) is the baseline global standard for cosmetic manufacturing. It covers personnel, premises, equipment, raw materials, production, QC, and documentation. If a manufacturer cannot demonstrate ISO 22716 compliance or an equivalent GMP audit, do not proceed regardless of their quoted price. This certification is required for EU market entry and is increasingly expected by U.S. retail buyers. FDA facility registration is required for cosmetic manufacturers selling into the United States under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). As of December 2023, all facilities that manufacture or process cosmetics for U.S. sale must be registered with the FDA and must have facility registration numbers. Verify your manufacturer's registration in the FDA's public database before signing any agreement. COSMOS or Ecocert certification is necessary if you plan to market your TXA scrub as organic or natural. Note that tranexamic acid itself is a synthetic amino acid derivative and will not qualify under COSMOS organic standards — you would need to position the product as "COSMOS Natural" at most, meaning all other ingredients must meet natural origin index requirements. Leaping Bunny or PETA cruelty-free certification covers your supply chain's animal testing practices. These are brand-level certifications but require manufacturer cooperation in completing supply chain questionnaires. If cruelty-free is a brand pillar, confirm the manufacturer is willing to participate in the audit process. For EU market entry specifically, you need a Responsible Person (RP) established in the EU, a complete Product Information File (PIF), and a CPSR signed by a qualified safety assessor. The manufacturer does not need to be EU-based, but they must be able to supply all technical documentation — full formula with INCI names, raw material COAs, stability data, micro testing results, and method of manufacture — to support the PIF. California Safe Cosmetics Program reporting is required if you sell in California and any ingredient appears on the California Safe Cosmetics Act list. This is a brand-level compliance obligation, but your manufacturer must supply complete formula disclosure to enable you to comply. Proposition 65 warnings may be required if fragrance components or preservatives contain listed substances above threshold levels. Finally, if you are targeting professional or clinical spa channels, some buyers require NSF or USP documentation on raw materials. This is less common in the scrub category but worth asking about if your distribution strategy includes medical spas or dermatologist offices.

Yes, stacking additional actives with tranexamic acid in a body scrub is common and, when done well, can create a more compelling product story and measurably better consumer results. However, compatibility, stability, and regulatory implications must be evaluated for every active you add. Niacinamide (vitamin B3) at 2–5% is the most popular TXA co-active for brightening and pore-minimizing claims. The combination is well-studied for hyperpigmentation. The formulation consideration is that niacinamide can react with certain ascorbic acid derivatives to form nicotinic acid (a skin-flushing compound) — so if you want to stack vitamin C as well, your cosmetic chemist must choose a stable vitamin C ester (ascorbyl glucoside, 3-O-ethyl ascorbic acid) rather than L-ascorbic acid. AHA/BHA exfoliants (glycolic acid, lactic acid, salicylic acid) can be combined with TXA for a chemical-plus-physical exfoliation hybrid scrub. The challenge is pH — AHAs are most effective at pH 3.5–4.5, while TXA is most stable at 5.5–6.5. A compromise pH of around 5.0 is sometimes used, but your cosmetic chemist must run stability and efficacy tests at the chosen pH, not assume published efficacy data at different pH ranges will translate. Azelaic acid at 5–10% complements TXA's mechanism and adds antibacterial benefits useful for body acne and KP (keratosis pilaris) positioning. Azelaic acid is only slightly water-soluble, so it requires a skilled emulsion chemist to incorporate homogeneously into a scrub base without grittiness or separation. Retinol and retinoids are generally not recommended in rinse-off scrub formats — contact time is too short for meaningful retinization, and the combination of physical exfoliation with retinol can cause irritation on some users. Skip this combination in a scrub; reserve retinol for your leave-on follow-up product if your brand offers one. Peptides and growth factors are increasingly appearing in premium body scrub formulations, but they add significant cost ($2–$8 per unit depending on peptide type and concentration) and may have limited benefit in a rinse-off format where dwell time is short. If peptides are a brand differentiator, validate the claim with an in-use study or consumer perception panel rather than relying on ingredient-supplier in-vitro data. From a regulatory standpoint, each active you add must be reviewed for its own regulatory status in your target markets. AJ Cosmo Labs connects you with cosmetic chemists who specialize in active-ingredient formulation and can advise on combinations that are both commercially compelling and compliance-ready before you commit to a production run.